Database
As part of its curating function, the Global Observatory collects, summarizes, and sorts resources relevant to the ethics and governance of emerging biotechnologies. Use the “Search and Filter” box on the left side of the page to navigate the resources in this database.
Search and Filter
2020-07
Kirstin Rw Matthews , Daniel Moralí
The authors review national policies and legislation for IVF, stem cells and human embryo research in the 22 research and development investing nations, focusing on whether they had restrictions for research on either human embryos or so-called “embryoids.” The review determined whether such researc
2020-07
Grant Castelyn
The author analyzes the main justifications provided by the Warnock committee for the 14-day limit of embryo research in vitro and finds them unconvincing; discussions about extending the limit must determine whether the limit was valid in the first place.
2020-04
Roberto Andorno , Françoise Baylis , Marcy Darnovsky , Donna Dickenson , Hille Haker , Katie Hasson , Leah Lowthorp , George J. Annas , Catherine Bourgain , Katherine Drabiak , Sigrid Graumann , Katrin Grüber , Matthias Kaiser , David King , Regine Kollek , Calum MacKellar , Jing-Bao Nie , Osagie K. Obasogie , Mirriam Tyebally Fang , Gabriele Werner-Felmayer , Jana Zuscinova
Following a meeting at the Brocher Foundation in Switzerland, a group of public interest advocates released this statement on heritable human genome editing. They viewed this statement as a corrective to the many statements released by experts in the sciences and bioethics.
2020-03
National Advisory Committee on Ethics in Life Sciences and Health, France, German Ethics Council, Nuffield Council on Bioethics
The ethics councils of three major European nations—France, Germany, and the UK—jointly authored this statement on the ethics of human germline genome editing.
2020
National Academy of Medicine, National Academy of Sciences, and The Royal Society International Commission on the Clinical Use of Human Germline Genome Editing
Produced by a joint commission of leading science advisory bodies in the USA and UK, this was the first major advisory report to be spurred by news that gene-edited twins had been born in China in 2018.